U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C35H31N6O4.Na
Molecular Weight 622.6482
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of DERSALAZINE SODIUM

SMILES

[Na+].CC1=NC2=CN=CC=C2N1CC3CCN(CC3)C(=O)\C=C(\C4=CC=CC=C4)C5=CC=C(C=C5)\N=N\C6=CC=C(O)C(=C6)C([O-])=O

InChI

InChIKey=YLEYSRAGECECMB-UUHDFEAYSA-M
InChI=1S/C35H32N6O4.Na/c1-23-37-31-21-36-16-13-32(31)41(23)22-24-14-17-40(18-15-24)34(43)20-29(25-5-3-2-4-6-25)26-7-9-27(10-8-26)38-39-28-11-12-33(42)30(19-28)35(44)45;/h2-13,16,19-21,24,42H,14-15,17-18,22H2,1H3,(H,44,45);/q;+1/p-1/b29-20-,39-38+;

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C35H31N6O4
Molecular Weight 599.6584
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 2
Optical Activity NONE

Dersalazine is a locally-acting compound. It is a potent platelet activating factor (PAF)-antagonist. Dersalazine inhibited IL-1beta or TNF-alpha production in THP-1 or U937 cells, respectively. Dersalazine sodium reduced colonic proinflammatory cytokines IL-1b, IL-6, and IL-17 in dextran sodium sulphate (DSS)–induced colitis. After oral administration, dersalazine sodium is mostly unabsorbed until it reaches the large bowel where the azo bond is reduced by bacteria releasing the active compound. Dersalazine had been in phase I clinical trial for the treatment of ulcerative colitis. No serious adverse reactions were detected in clinical trial. However, no recent development has been reported.

Approval Year

Sample Use Guides

1200 mg/12 h for 4 weeks
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 01:39:40 GMT 2023
Edited
by admin
on Sat Dec 16 01:39:40 GMT 2023
Record UNII
BAB844203H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DERSALAZINE SODIUM
WHO-DD  
Common Name English
BENZOIC ACID, 2-HYDROXY-5-(2-(4-((1Z)-3-(4-((2-METHYL-1H-IMIDAZO(4,5-C)PYRIDIN-1-YL)METHYL)-1-PIPERIDINYL)-3-OXO-1-PHENYL-1-PROPEN-1-YL)PHENYL)DIAZENYL)-, SODIUM SALT (1:1)
Common Name English
UR-12746S
Code English
DERSALAZINE SODIUM [WHO-DD]
Common Name English
SODIUM DERSALAZINE
Common Name English
Code System Code Type Description
PUBCHEM
57331752
Created by admin on Sat Dec 16 01:39:40 GMT 2023 , Edited by admin on Sat Dec 16 01:39:40 GMT 2023
PRIMARY
FDA UNII
BAB844203H
Created by admin on Sat Dec 16 01:39:40 GMT 2023 , Edited by admin on Sat Dec 16 01:39:40 GMT 2023
PRIMARY
DRUG BANK
DBSALT002003
Created by admin on Sat Dec 16 01:39:40 GMT 2023 , Edited by admin on Sat Dec 16 01:39:40 GMT 2023
PRIMARY
CAS
367249-56-7
Created by admin on Sat Dec 16 01:39:40 GMT 2023 , Edited by admin on Sat Dec 16 01:39:40 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE